Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · Real-Time Price · USD
23.74
+0.40 (1.71%)
At close: Dec 10, 2025, 4:00 PM EST
24.00
+0.26 (1.10%)
After-hours: Dec 10, 2025, 7:13 PM EST
Edgewise Therapeutics Market Cap
Edgewise Therapeutics has a market cap or net worth of $2.51 billion as of December 10, 2025. Its market cap has decreased by -17.00% in one year.
Market Cap
2.51B
Enterprise Value
1.95B
1-Year Change
-17.00%
Ranking
Category
Stock Price
$23.74
Market Cap Chart
Since the IPO on March 26, 2021, Edgewise Therapeutics's market cap has increased from $761.07M to $2.51B, an increase of 230.23%. That is a compound annual growth rate of 28.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 9, 2025 | 2.47B | -2.26% |
| Dec 31, 2024 | 2.53B | 264.15% |
| Dec 29, 2023 | 694.27M | 22.85% |
| Dec 30, 2022 | 565.13M | -24.97% |
| Dec 31, 2021 | 753.24M | -1.03% |
| Mar 26, 2021 | 761.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 893.23B |
| Johnson & Johnson | 485.76B |
| AbbVie | 394.34B |
| UnitedHealth Group | 293.15B |
| AstraZeneca | 280.30B |
| Novartis AG | 253.21B |
| Merck & Co. | 245.55B |
| Thermo Fisher Scientific | 213.48B |